Catecholamine depletion and adrenergic neurone blockade: studies with debrisoquine.
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000578:Amidines / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D000818:Animals; D002415:Cats; D003913:Dextroamphetamine / Q000494:pharmacology; D007546:Isoquinolines / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D009638:Norepinephrine / Q000378:metabolism*; D013154:Spleen / Q000294:innervation / Q000378:metabolism*; D013565:Sympatholytics / Q000037:antagonists & inhibitors / Q000494:pharmacology*
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D000578:Amidines; D007546:Isoquinolines; D013565:Sympatholytics; D003913:Dextroamphetamine; D009638:Norepinephrine